Galán-Díez, M., Borot, F., Ali, A. M., Zhao, J., Gil-Iturbe, E., Shan, X., Luo, N., Liu, Y., Huang, X.-P., Bisikirska, B., Labella, R., Kurland, I., Roth, B. L., Quick, M., Mukherjee, S., Rabadán, R., Carroll, M., Raza, A., & Kousteni, S. (2022). Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia. Cancer Discovery, 12(4), 1106–1127. https://doi.org/10.1158/2159-8290.cd-21-0692

Bagheri, M., Wang, C., Shi, M., Manouchehri, A., Murray, K. T., Murphy, M. B., Shaffer, C. M., Singh, K., Davis, L. K., Jarvik, G. P., Stanaway, I. B., Hebbring, S., Reilly, M. P., Gerszten, R. E., Wang, T. J., Mosley, J. D., & Ferguson, J. F. (2021). The genetic architecture of plasma kynurenine includes cardiometabolic disease mechanisms associated with the SH2B3 gene. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-95154-9